Cyclosporin A and its analogs inhibit hepatitis B virus entry into cultured hepatocytes through targeting a membrane transporter, sodium taurocholate cotransporting polypeptide (NTCP)

Chronic hepatitis B virus (HBV) infection is a major public health problem worldwide. Although nucleos(t)ide analogs inhibiting viral reverse transcriptase are clinically available as anti‐HBV agents, emergence of drug‐resistant viruses highlights the need for new anti‐HBV agents interfering with ot...

Descripción completa

Detalles Bibliográficos
Autores principales: Watashi, Koichi, Sluder, Ann, Daito, Takuji, Matsunaga, Satoko, Ryo, Akihide, Nagamori, Shushi, Iwamoto, Masashi, Nakajima, Syo, Tsukuda, Senko, Borroto‐Esoda, Katyna, Sugiyama, Masaya, Tanaka, Yasuhito, Kanai, Yoshikatsu, Kusuhara, Hiroyuki, Mizokami, Masashi, Wakita, Takaji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2014
Materias:
Viral Hepatitis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4265264/
https://www.ncbi.nlm.nih.gov/pubmed/24375637
http://dx.doi.org/10.1002/hep.26982

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4265264/
https://www.ncbi.nlm.nih.gov/pubmed/24375637
http://dx.doi.org/10.1002/hep.26982

Ejemplares similares